Average Co-Inventor Count = 9.22
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (11 from 1,536 patents)
2. Boehringer Ingelheim Pharmaceuticals, Inc. (4 from 276 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
15 patents:
1. 10858342 - Bicyclic imidazole derivatives useful for the treatment of renal diseases, cardiovascular diseases and fibrotic diseases
2. 9890171 - Aldosterone synthase inhibitors
3. 9403830 - Inhibitors of leukotriene production
4. 9334285 - Aldosterone synthase inhibitors
5. 9181272 - Aldosterone synthase inhibitors
6. 9079880 - Rho kinase inhibitors
7. 9000154 - Rho kinase inhibitors
8. 8697911 - Rho kinase inhibitors
9. 8450317 - CXCR3 receptor antagonists
10. 8362249 - CXCR3 receptor antagonists
11. 8093266 - Rho kinase inhibitors
12. 7405225 - Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
13. 7119102 - [object Object]
14. 6974870 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
15. 6964956 - Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses